Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which there is currently no approved pharmacological
Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which...
Investegate announcements from COMPASS Pathways, COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.
Investegate announcements from COMPASS Pathways, COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting